<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: Ischemic <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> offers a favorable terrain for left ventricular (LV) <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation; however, left artial appendage (LAA) may be an additional source of <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> in patients with <z:mp ids='MP_0004937'>dilated heart</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>The main objectives of this study were to determine the prevalence of LV and LAA <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> in patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> ischemic <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> in sinus rhythm, as well as to reveal echocardiographic predictors for <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The study included 57 patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> dilated ischemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> in sinus rhythm, who were not under oral anticoagulation therapy </plain></SENT>
<SENT sid="3" pm="."><plain>Exclusion criteria included patients with: swallowing problems, <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, idiopathic and/or non-ischemic <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo>, <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo>/flatter, severe systolic dysfunction </plain></SENT>
<SENT sid="4" pm="."><plain>Transthoracic echocardiography and transesophageal echocardiography were obtained for each patient </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Mean patient age was 62 +/- 10.5 years, mean LV end diastolic diameter was 67.2 +/- 5.8 mm, whereas mean LV ejection fraction (EF) was 37.1 +/- 4.3% </plain></SENT>
<SENT sid="6" pm="."><plain>LV <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> was detected in 11 (19.3%) patients; while 23 (40.3%) patients had LAA <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>In a multiple regression analysis LV size (p = 0.05) and lack of aspirin therapy (p = 0.02) showed to be independent LV <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> predictors, whereas lower LV EF (p = 0.02) and larger LAA maximal area (p = 0.004) demonstrated to be independent predictors of LAA <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: We consider that our study sheds light to the high possibility of LAA <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> formation in addition to LV <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> in patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> dilated ischemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> in sinus rhythm </plain></SENT>
<SENT sid="9" pm="."><plain>LV size, LV EF, LAA maximal area and lack of aspirin therapy are shown to be independent predictors of left heart chamber <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> in this patient category </plain></SENT>
</text></document>